These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5885954)

  • 1. Iron studies of thalassaemic erythrocytes after splenectomy.
    Malamos B; Gyftaki E; Proukakis C; Poulios N
    Nature; 1965 Aug; 207(999):872-3. PubMed ID: 5885954
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of iron overload in Cooley's anemia.
    Cohen A; Mizanin J; Schwartz E
    Ann N Y Acad Sci; 1985; 445():274-81. PubMed ID: 3860130
    [No Abstract]   [Full Text] [Related]  

  • 3. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M
    Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INDICATIONS AND LIMITATIONS OF SPLENECTOMY IN THE TREATMENT OF THALASSEMIA MAJOR. CONSIDERATIONS ON 17 CASES].
    NICOLA P; D OLEGGIO AV; MOROSINI FIANDINO G
    Minerva Pediatr; 1963 Oct; 15():1047-56. PubMed ID: 14101059
    [No Abstract]   [Full Text] [Related]  

  • 5. Splenectomy, iron overload and liver cirrhosis in beta-thalassemia major.
    Okon E; Levij IS; Rachmilewitz EA
    Acta Haematol; 1976; 56(3):142-50. PubMed ID: 826069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
    [No Abstract]   [Full Text] [Related]  

  • 7. Dl-alpha-tocopherol, iron, and lipofuscin in thalassemia.
    Hyman CB; Landing B; Alfin-Slater R; Kozak L; Weitzman J; Ortega JA
    Ann N Y Acad Sci; 1974; 232(0):211-20. PubMed ID: 4528518
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron concentration in teeth of patients with and without beta-thalassaemia major.
    Garfunkel A; Kantzuker M; Gedalia I; Chevion M
    Arch Oral Biol; 1979; 24(10-11):829-31. PubMed ID: 295607
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic erythroblastopenia: a condition of defect in the utilization of iron with increase of the deposits pool. Study of iron kinetics in 3 cases].
    Patti A; Caronia F; Guarnaccia C; Mauro B
    Biol Lat; 1968; 21(1):61-72. PubMed ID: 4899170
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro synthesis of haemoglobin from Fe59 and leucine-C14 by normal, sickle-cell and thalassaemic immature red cells.
    Malamos B; Gyftaki E; Elias-Kesse M; Christakopoulos P
    Acta Haematol; 1967; 38(4):200-8. PubMed ID: 4964888
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.
    Tavazzi D; Duca L; Graziadei G; Comino A; Fiorelli G; Cappellini MD
    Br J Haematol; 2001 Jan; 112(1):48-50. PubMed ID: 11167782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation in iron-overloaded spleens.
    Heys AD; Dormandy TL
    Clin Sci (Lond); 1981 Mar; 60(3):295-301. PubMed ID: 6786818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
    Kontopoulou-Griva I; Hatzidimitriou-Papazacharia K; Spiliotopoulou J; Tsagarakis N; Digenopoulou E
    Birth Defects Orig Artic Ser; 1988; 23(5B):111-6. PubMed ID: 3390532
    [No Abstract]   [Full Text] [Related]  

  • 14. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients.
    Piomelli S; Graziano J; Karpatkin M; Dudell GG; Hart D; Hilgartner M; Khanna K; Valdes-Cruz LM; Vora S
    Ann N Y Acad Sci; 1980; 344():409-17. PubMed ID: 6930881
    [No Abstract]   [Full Text] [Related]  

  • 15. UPTAKE OF FE-59 BY ACID INSOLUBLE ELEMENTS OF NORMAL AND THALASSAEMIC HAEMOLYSATES. IN VITRO STUDIES.
    MALAMOS B; GYFTAKI E; PROUKAKIS C
    Acta Haematol; 1964 Feb; 31():79-89. PubMed ID: 14131785
    [No Abstract]   [Full Text] [Related]  

  • 16. The susceptibility to autoxidation of human red cell lipids in health and disease.
    Stocks J; Offerman EL; Modell CB; Dormandy TL
    Br J Haematol; 1972 Dec; 23(6):713-24. PubMed ID: 4646825
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E; Bianco I; Graziani B; Lerone M; Valente M; Congedo P; Ponzini D; Costantini S
    Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G
    Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996
    [No Abstract]   [Full Text] [Related]  

  • 19. The phospholipids of normal and thalassaemic erythrocytes.
    Nicolopoulos D; Agathopoulos A; Constantoulakis M
    Br J Haematol; 1966 Mar; 12(2):189-94. PubMed ID: 5932547
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythrokinetic studies in thalassemia with simultaneous radioactive tracers (Fe59 and Cr51).
    Schettini F; Meloni T; Costa S
    Acta Haematol; 1967; 37(2):65-87. PubMed ID: 4961918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.